Categories: MedicaidNews

Equip Welcomes Adults with Expansion of Virtual Evidence-Based Eating Disorder Treatment

Following years of growth and industry-changing outcomes, the leader in eating disorder treatment announces awaited program extension

SAN DIEGO, Sept. 19, 2023 (GLOBE NEWSWIRE) — Equip, the leading provider of virtual, evidence-based eating disorder treatment in the U.S., today announced the expansion of its services to adults, ensuring that everyone in the U.S. who needs it has access to care. Nearly 30 million Americans will struggle with an eating disorder in their lifetime, but only a small fraction get care that results in lasting recovery. Equip’s expansion to adults cements the company’s position as the leading eating disorder treatment provider and closes significant gaps in the traditional treatment landscape.

“Since Equip’s inception in 2019, we have been laser-focused on providing effective treatment to thousands of adolescents and young adults with eating disorders,” said Dr. Erin Parks, Chief Clinical Officer and Co-Founder of Equip. “We know, though, that eating disorders don’t discriminate by age, gender, socioeconomic status, or body size. By broadening our treatment to adults, we are expanding hope to every person with an eating disorder that they can rediscover a more meaningful life on the other side of their illness.”

This expansion is a landmark moment for the company, showcasing continued momentum. It’s buoyed by a recent additional investment from General Catalyst, one of Equip’s early investors, which will fuel the company’s expansion and mission to treat everyone in need of eating disorder care.

Earlier this year, Equip published its first Annual Outcomes Report, which revealed that patients saw their symptoms reduced by at least 50 percent in their first five months of treatment. Additionally, 94 percent of all Equip patients had their treatment covered by insurance as a result of strategic partnerships with many leading commercial insurance plans and Medicaid. Today, Equip treats patients in all 50 U.S. states, including the nine U.S. states that lack an in-person treatment center entirely.

About Equip
Equip is the leading virtual, evidence-based eating disorder treatment program on a mission to ensure that everyone with an eating disorder can access treatment that works. Created by clinical experts in the field and people with lived experience, Equip builds upon evidence-based treatments to empower individuals to reach lasting recovery. All Equip patients receive a dedicated care team, including a therapist, dietitian, physician, and peer and family mentor. The company operates in all 50 states and is partnered with most major health insurance plans. For more information, visit equip.health.

Contact:
Equip Media Relations
press@equip.health

LaunchSquad for Equip
equip@launchsquad.com

Staff

Recent Posts

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…

5 hours ago

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

8 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

8 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

8 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

8 hours ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

8 hours ago